JA Solar Holdings Co. Ltd - JASO - reported that it has entered into an agreement with Solarhybrid AG, to supply 19 MW of solar modules to Solarhybrid’s Allstedt I solar power plant in Halle, Germany.
Peregrine Pharmaceuticals Inc - PPHM - reported preliminary results related with its Bavituximab from a randomized Phase II trial showing a 50% improvement in overall tumor response rates in non-small cell lung cancer patients
